Humana AB (publ) (STO:HUM)
| Market Cap | 2.46B |
| Revenue (ttm) | 10.22B |
| Net Income (ttm) | 240.00M |
| Shares Out | 49.22M |
| EPS (ttm) | 4.74 |
| PE Ratio | 10.56 |
| Forward PE | 8.72 |
| Dividend | 1.00 (2.00%) |
| Ex-Dividend Date | n/a |
| Volume | 18,664 |
| Average Volume | 77,229 |
| Open | 50.00 |
| Previous Close | 50.00 |
| Day's Range | 49.10 - 50.00 |
| 52-Week Range | 32.70 - 52.40 |
| Beta | 0.21 |
| RSI | 49.17 |
| Earnings Date | Feb 6, 2026 |
About Humana AB
Humana AB (publ) provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark. It operates through three segments: Sweden, Finland, and Norway. The company provides care and treatment for psychosocial disorders, mental illness, and functional impairment; residential care homes; family care services; short-term, short term housing, day crare, and special service housing; outpatient care; assisted living homes; and specially adapted housing for individuals with functional impairments. It also offers... [Read more]
Financial Performance
In 2024, Humana AB's revenue was 10.30 billion, an increase of 6.78% compared to the previous year's 9.64 billion. Earnings were 144.00 million, a decrease of -18.18%.
Financial StatementsNews
Marquette Asset Management, LLC Sells 9 Shares of Humana Inc (HUM)
Marquette Asset Management, LLC Sells 9 Shares of Humana Inc (HUM)
The Zacks Analyst Blog Highlights UnitedHealth Group, Centene, Humana and Elevance Health
UnitedHealth Group, Centene, Humana and Elevance face new uncertainty as Trump's Great Healthcare Plan targets premiums, drug prices and transparency.
Humana Partners With Atlas to Enhance Cancer Care for Seniors
HUM teams up with Atlas Oncology to make a cancer care model available for its eligible MA members in TN and MS starting in 2026.
Humana Expands Cancer Care for Medicare Advantage Members Through Atlas Oncology Partnership
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana expands cancer care for eligible Medicare Advantage members in Tennessee and Mississippi through Atlas Oncology partnership.
CenterWell Pharmacy to Dispense Obesity Management Medications as Part of New, Employer-Focused Program
LOUISVILLE, Ky.--(BUSINESS WIRE)--CenterWell Pharmacy to dispense obesity management medications as part of new, employer-focused program.
Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Ea...
February 27th Options Now Available For Humana (HUM)
Investors in Humana Inc. (Symbol: HUM) saw new options begin trading today, for the February 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the HUM options ch...
Humana (HUM): Wells Fargo Downgrades Rating to Equal-Weight | HUM Stock News
Humana (HUM): Wells Fargo Downgrades Rating to Equal-Weight | HUM Stock News
Humana (HUM) Downgraded by Wells Fargo Amid Margin Concerns
Humana (HUM) Downgraded by Wells Fargo Amid Margin Concerns
Unpacking the Latest Options Trading Trends in Humana
Whales with a lot of money to spend have taken a noticeably bearish stance on Humana . Looking at options history for Humana (NYSE: HUM) we detected 26 trades. If we consider the specifics of each tr...
February 2026 Options Now Available For Humana (HUM)
Investors in Humana Inc. (Symbol: HUM) saw new options begin trading today, for the February 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the HUM options ch...
Why Humana Deserves Patience Now: Too Early to Buy, Too Risky to Sell
HUM sits at a crossroads as Medicare Advantage pressures cap near-term upside, but resilience versus peers argues for patience, not panic.
Validea Detailed Fundamental Analysis - HUM
Below is Validea's guru fundamental report for HUMANA INC (HUM). Of the 22 guru strategies we follow, HUM rates highest using our Acquirer's Multiple Investor model based on the published strategy of ...
Humana: Margin Headwinds To Persist In 2026
Discover how HUM plans to boost Medicare Advantage margins amid rising costs and regulatory risks.
UnitedHealth (UNH) and Humana (HUM) Lead Medicare Cost Overruns
UnitedHealth (UNH) and Humana (HUM) Lead Medicare Cost Overruns
UnitedHealth, Humana lead in excessive Medicare drug refill costs: study
Why Humana (HUM) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Ex-Dividend Reminder: Pennymac Mortgage Investment Trust, TowneBank and Humana
Looking at the universe of stocks we cover at Dividend Channel, on 12/26/25, Pennymac Mortgage Investment Trust (Symbol: PMT), TowneBank (Symbol: TOWN), and Humana Inc. (Symbol: HUM) will all trade ex...
HUM Quantitative Stock Analysis
Below is Validea's guru fundamental report for HUMANA INC (HUM). Of the 22 guru strategies we follow, HUM rates highest using our Acquirer's Multiple Investor model based on the published strategy of ...
Morgan Stanley Lowers Humana (HUM) Price Target | HUM Stock News
Morgan Stanley Lowers Humana (HUM) Price Target | HUM Stock News
HUM August 2026 Options Begin Trading
Investors in Humana Inc. (Symbol: HUM) saw new options become available today, for the August 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the ...
Humana (HUM) Secures $7.34 Billion Contract from Defense Health Agency
Humana (HUM) Secures $7.34 Billion Contract from Defense Health Agency
Pentagon awards Humana a $7.3 billion health care deal
The U.S. Defense Department on Wednesday said it was exercising an option to award Humana a $7.3 billion deal for health care and administrative support services.
Humana, Nurses on Boards Coalition Announce New Partnership to Mentor Emerging Nurses
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana, Nurses on Boards Coalition announce new partnership to mentor emerging nurses.